Gestational Diabetes
Also known as: Gestational Diabetes Mellitus, GDM
Gestational diabetes is a form of high blood sugar that develops during pregnancy in women who did not have diabetes before. It typically develops in the second or third trimester when placental hormones interfere with insulin action. With proper management, most women have healthy pregnancies, but it increases the future risk of type 2 diabetes.
Last updated November 10, 2026
Understanding Gestational Diabetes
Gestational diabetes (GDM) is glucose intolerance first recognized during pregnancy in a woman who did not have diabetes beforehand; by definition it is found by screening, because it rarely causes symptoms. It is now one of the most common complications of pregnancy in the United States: the rate recorded on birth certificates rose from 6 percent of live births in 2016 to 7.8 percent in 2020 and about 8.3 percent in 2021, roughly 300,000 pregnancies a year, driven by rising pre-pregnancy weight and older maternal age. Rates are highest in Asian American and Hispanic women and in women over 35, and a woman who has had it once has about a 50 percent chance of having it in her next pregnancy. Worldwide the International Diabetes Federation estimates that one pregnancy in seven is affected. The diagnosis frightens most people, but the evidence is reassuring: treated GDM carries only slightly higher risks than a pregnancy without it, and the diagnosis is often the first warning of a long-term tendency to type 2 diabetes that can be acted on years early.
Pregnancy is designed to be insulin resistant. From mid-pregnancy the placenta produces human placental lactogen, placental growth hormone, progesterone and cortisol, which blunt the action of insulin in the mother's muscle and fat by 40 to 60 percent so that more glucose stays in the blood for the baby. A healthy pancreas answers by doubling or tripling insulin output. Gestational diabetes happens when the beta cells cannot keep up, usually because they were already working near capacity: pre-existing insulin resistance from excess weight or polycystic ovary syndrome, a family history of type 2 diabetes, or a genetic limit on beta-cell reserve. That is why GDM appears at 24 to 28 weeks, when placental hormones peak, and why it disappears within days of delivery. The extra glucose crosses to the baby, whose own pancreas responds with extra insulin, which acts as a growth hormone in the fetus; the result is a larger baby with more fat around the shoulders, and a newborn whose insulin stays high after the sugar supply stops, causing low blood sugar in the first hours.
Screening is near-universal. The American College of Obstetricians and Gynecologists recommends a 50 g glucose challenge at 24 to 28 weeks, followed by a 3-hour 100 g tolerance test if the 1-hour value is 130 to 140 mg/dL or higher; many centers instead use a single-step 75 g test with cut-offs of 92 fasting, 180 at 1 hour or 153 mg/dL at 2 hours. Treatment works. In the Australian ACHOIS trial of 1,000 women, treating mild GDM cut serious perinatal complications from 4 percent to 1 percent, and a 958-woman US trial more than halved the rate of large babies (14.3 to 5.9 percent) and reduced shoulder dystocia, cesarean delivery and preeclampsia. Diet and daily activity are enough for 70 to 85 percent of women. If fasting glucose stays above 95 mg/dL or 1-hour values above 140, ACOG and the American Diabetes Association recommend insulin first because it does not cross the placenta; metformin is an alternative when insulin is declined, though it reaches the baby and about half of women on it eventually need insulin, and glyburide is now discouraged.
The natural approaches with real trial evidence are prevention-oriented, which makes sense: the problem is beta-cell reserve, not a missing nutrient. Myo-inositol, an insulin-sensitizing sugar alcohol, cut the incidence of GDM by more than half in Italian trials of at-risk women who started 4 g a day in the first trimester, and a 2023 Cochrane review of 7 trials in 1,319 women found a similar reduction, with low certainty because most trials came from one country. Vitamin D in pregnancy reduced GDM risk by about half in a 2019 Cochrane analysis of small trials. Probiotics reduced it in one New Zealand trial but not in two larger ones, and Cochrane found no benefit, and possibly more preeclampsia, when they were used to treat established GDM. Magnesium improved fasting glucose in one 70-woman trial, and 800 mg of DHA daily did not prevent GDM in a trial of 2,399 women. Cinnamon, chromium, gymnema, berberine, bitter melon and fenugreek have no pregnancy trials or are unsafe: berberine can displace bilirubin and harm the newborn, and bitter melon and fenugreek have uterine effects. Nothing here replaces glucose monitoring and, when needed, insulin.
The most common mistake is cutting carbohydrates to almost nothing to chase perfect numbers. Fasting glucose in GDM is driven by overnight liver output and placental hormones, not by last night's dinner, so a woman eating 30 g of carbohydrate a day and still seeing a fasting value of 100 mg/dL concludes she is failing, when in fact she needs insulin, and meanwhile her body makes ketones from fat and the baby is short of fuel. Guidelines set a minimum of 175 g of carbohydrate a day, spread across three meals and two or three snacks, from slower-releasing sources paired with protein, and ketones in the urine are a sign of too little food, not too much. The second mistake is forgetting the test after the birth. The 75 g glucose tolerance test at 4 to 12 weeks postpartum, then an A1c or fasting glucose every 1 to 3 years for life, catches the type 2 diabetes that roughly half of women with GDM will develop within 10 to 15 years, yet fewer than half of women ever get the postpartum test.
At a Glance
- Common symptoms
- Often asymptomatic (detected through routine screening), Increased thirst, Frequent urination
- Main treatments
- Medical nutrition therapy with controlled carbohydrate intake, Regular physical activity as recommended by your provider, Blood glucose self-monitoring (fasting and post-meal levels)
- Category
- Endocrine · Affects approximately 2–10% of pregnancies in the United States
- See a doctor if
- You are pregnant and have risk factors for gestational diabetes
Symptoms
Causes
- Insulin resistance caused by placental hormones
- Inability of the pancreas to produce enough insulin to overcome resistance
- Genetic predisposition to insulin resistance
Risk Factors
- Overweight or obesity before pregnancy (BMI ≥25)
- Age over 25
- Family history of type 2 diabetes
- Previous gestational diabetes
- Polycystic ovary syndrome
- African American, Hispanic, Native American, Asian, or Pacific Islander descent
Diagnosis
- Glucose challenge test (GCT) at 24–28 weeks of pregnancy
- Oral glucose tolerance test (OGTT) for confirmation
- Early screening for high-risk women at the first prenatal visit
- Hemoglobin A1c to detect pre-existing diabetes
Treatment
- Medical nutrition therapy with controlled carbohydrate intake
- Regular physical activity as recommended by your provider
- Blood glucose self-monitoring (fasting and post-meal levels)
- Insulin therapy if diet and exercise do not achieve targets
- Metformin or glyburide as alternatives in some cases
- Increased fetal monitoring and delivery planning
Natural remedies for gestational diabetes: what the evidence says
Ranked by the strength of human evidence for gestational diabetes specifically. These sit alongside medical care, not in place of it.
Inositol
Moderate evidenceIn a randomized trial of 220 obese Italian women, 2 g myo-inositol plus folic acid twice daily from the first trimester reduced the incidence of GDM to 14 percent versus 33.6 percent with folic acid alone, and an earlier trial in 220 women with a family history of type 2 diabetes found 6 percent versus 15.3 percent. A 2023 Cochrane review of 7 trials (1,319 women) found myo-inositol may roughly halve GDM risk and lower fasting glucose, but rated the evidence low certainty because most trials were small, unblinded and from one country.
- Studied dose
- 2 g myo-inositol with 200 mcg folic acid twice daily (4 g/day) from the first trimester, as studied for prevention; the same dose has been used after diagnosis.
- Cautions
- Well tolerated; mild nausea or loose stools at higher doses. Do not use it to replace glucose monitoring or prescribed insulin, and tell your obstetric team you are taking it.
Vitamin D
Moderate evidenceA 2019 Cochrane review found vitamin D supplementation in pregnancy probably reduces the risk of gestational diabetes (4 trials, 446 women, risk roughly halved), along with preeclampsia and low birth weight, though the trials were small. In women already diagnosed, two 6-week Iranian trials of 54 and 56 women found 50,000 IU every 2 to 3 weeks, in one case with calcium, lowered fasting glucose and insulin resistance. Low vitamin D status is common in pregnancy; ask for a vitamin D level before choosing a dose.
- Studied dose
- 1,000 to 2,000 IU vitamin D3 daily as a routine pregnancy dose; up to 4,000 IU daily if a blood test shows deficiency, under clinician guidance.
- Cautions
- Do not exceed 4,000 IU a day in pregnancy without monitoring, because excess raises blood calcium. The high-dose bolus regimens used in trials should only be taken on medical advice.
Probiotics (Lactobacillus)
Preliminary evidenceIn a New Zealand trial of 423 women, Lactobacillus rhamnosus HN001 taken from 14 to 16 weeks lowered GDM incidence to 2.1 percent versus 6.5 percent with placebo, with the clearest effect in women over 35 and those with previous GDM. Two larger trials in overweight and obese women (411 and 439 participants) found no reduction, and a 2021 Cochrane review of probiotics for treating established GDM found no benefit and a possible increase in preeclampsia. The evidence is mixed and strain-specific.
- Studied dose
- Lactobacillus rhamnosus HN001, 6 billion CFU daily from the early second trimester, as studied for prevention; there is no proven dose for treatment.
- Cautions
- Generally safe in pregnancy, but given the preeclampsia signal in treatment trials, discuss it with your obstetric team and do not use it as a treatment for diagnosed GDM. Avoid in serious immune compromise.
Magnesium Glycinate
Preliminary evidenceIn a 6-week randomized trial of 70 women with GDM and low magnesium levels, 250 mg of magnesium daily lowered fasting glucose, insulin levels and insulin resistance compared with placebo, and fewer newborns in the magnesium group were admitted to hospital. It is a single small trial in women selected for low magnesium, so the evidence is preliminary; ask for a serum magnesium if you want to know whether it applies to you.
- Studied dose
- 250 mg elemental magnesium daily, as glycinate or citrate, with food, for 6 weeks, in women shown to be low.
- Cautions
- Loose stools at higher doses; keep below 350 mg a day from supplements in pregnancy unless prescribed. Separate from iron and thyroid medication by 2 hours, and avoid with kidney disease.
What matters day to day
- Walk for 10 to 15 minutes after each meal: in a crossover trial in 41 adults with type 2 diabetes, three 10-minute walks after meals lowered post-meal glucose by about 12 percent more than a single 30-minute walk at another time, and the mechanism, muscles pulling glucose from the blood, is the same in pregnancy.
- Spread at least 175 g of carbohydrate across 3 meals and 2 to 3 snacks, with the smallest carbohydrate portion at breakfast when morning cortisol makes insulin resistance highest; a bedtime snack with protein improves fasting numbers for some women.
- Check glucose 4 times a day, fasting and 1 or 2 hours after each meal, against targets of under 95 mg/dL fasting and under 140 at 1 hour or 120 at 2 hours, and log everything: medication decisions depend on the pattern over a week, not on single readings.
- Aim for 150 minutes a week of moderate activity such as brisk walking, swimming, stationary cycling or prenatal resistance training: a 2018 meta-analysis found prenatal exercise programs cut the odds of developing GDM by 38 percent, and the same activity lowers glucose once it is diagnosed.
- Keep weight gain within Institute of Medicine ranges, 25 to 35 lb for a normal starting BMI, 15 to 25 if overweight and 11 to 20 if obese: gain above the range raises the risk of a large baby and of weight retention afterward.
- Breastfeed if you can, for as long as you can: in a cohort of 1,035 women with GDM, those who breastfed cut their risk of type 2 diabetes over the next 2 years by 36 to 57 percent depending on duration and intensity, compared with those who did not.
Prevention
- Achieve a healthy weight before pregnancy
- Eat a balanced, nutrient-rich diet
- Exercise regularly before and during pregnancy
When to See a Doctor
- You are pregnant and have risk factors for gestational diabetes
- Routine screening tests show elevated blood sugar
- You experience increased thirst, urination, or fatigue during pregnancy
- You had gestational diabetes in a previous pregnancy
Frequently Asked Questions
References
- American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 190: Gestational diabetes mellitus. Obstetrics & Gynecology (2018)
- American Diabetes Association Professional Practice Committee. 15. Management of diabetes in pregnancy: Standards of Care in Diabetes-2025. Diabetes Care (2025)
- Crowther CA, Hiller JE, Moss JR, et al.. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. New England Journal of Medicine (2005)
- Landon MB, Spong CY, Thom E, et al.. A multicenter, randomized trial of treatment for mild gestational diabetes. New England Journal of Medicine (2009)
- Rowan JA, Hague WM, Gao W, Battin MR, Moore MP. Metformin versus insulin for the treatment of gestational diabetes. New England Journal of Medicine (2008)
- Gregory ECW, Ely DM. Trends and characteristics in gestational diabetes mellitus, United States, 2016-2020. National Vital Statistics Reports (2022)
- D'Anna R, Di Benedetto A, Scilipoti A, et al.. Myo-inositol supplementation for prevention of gestational diabetes in obese pregnant women: a randomized controlled trial. Obstetrics & Gynecology (2015)
- Wickens KL, Barthow CA, Murphy R, et al.. Early pregnancy probiotic supplementation with Lactobacillus rhamnosus HN001 may reduce the prevalence of gestational diabetes mellitus: a randomised controlled trial. British Journal of Nutrition (2017)
- Gunderson EP, Hurston SR, Ning X, et al.. Lactation and progression to type 2 diabetes mellitus after gestational diabetes mellitus: a prospective cohort study. Annals of Internal Medicine (2015)
- National Institute of Diabetes and Digestive and Kidney Diseases. Gestational Diabetes (2024)View source
Related Conditions
Lab tests that relate to gestational diabetes
Have questions about Gestational Diabetes?
Ask Mother Nature AI for personalized, evidence-based guidance.
Medical Disclaimer: This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider.
Content reviewed against peer-reviewed medical literature and clinical guidelines. Read our editorial standards.